Company Valuation: DIAGNOS Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2021 2022 2023 2024 2025 2026
Market Cap 1 35.98 17.37 24.36 17.84 30.56 33.11
Change - -51.72% 40.26% -26.75% 71.25% 8.36%
Enterprise Value (EV) 1 35.09 17.63 26.37 20.81 30.4 32.59
Change - -49.75% 49.55% -21.08% 46.05% 7.22%
P/E -16.6x -6.59x -9.68x -5.48x -6.18x -6.51x
PBR 32.1x -153x -12.5x -5.9x 131x 48.2x
PEG - -0.4x 1.59x -0.3x -0.5x 0.5x
Capitalization / Revenue 135x 39.6x 50.2x 105x 294x 506x
EV / Revenue 131x 40.2x 54.3x 122x 293x 498x
EV / EBITDA -15.7x -6.71x -12x -8.06x -7.99x -7.67x
EV / EBIT -15.4x -6.63x -11.8x -7.98x -7.95x -7.64x
EV / FCF -41.8x -14.6x -21.6x -13.7x -11.7x -13.2x
FCF Yield -2.39% -6.84% -4.63% -7.32% -8.55% -7.57%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0325 -0.0379 -0.0356 -0.0429 -0.0486 -0.0422
Distribution rate - - - - - -
Net sales 1 0.2671 0.4388 0.4857 0.1702 0.1038 0.0655
EBITDA 1 -2.239 -2.626 -2.203 -2.583 -3.806 -4.25
EBIT 1 -2.283 -2.66 -2.237 -2.607 -3.824 -4.263
Net income 1 -2.051 -2.608 -2.481 -3.121 -4.286 -4.555
Net Debt 1 -0.8904 0.2635 2.008 2.967 -0.1637 -0.5251
Reference price 2 0.5400 0.2500 0.3450 0.2350 0.3000 0.2750
Nbr of stocks (in thousands) 66,626 69,474 70,611 75,934 101,863 120,413
Announcement Date 6/8/21 A 7/13/22 A 7/13/23 A 7/17/24 A 5/28/25 A 6/11/26 A
1CAD in Million2CAD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 31.91M
25.03x4.04x14.03x2.7% 237B
23.05x4.84x11.87x0.72% 198B
16.05x1.83x9.4x2.95% 139B
-134.06x18.45x101.45x-.--% 119B
-565.49x40.19x165.11x-.--% 117B
16.28x2.93x11.32x4.94% 95.11B
22.8x5.91x14.51x2.48% 68.03B
15.27x2.22x9.43x4.99% 49.59B
25.04x2.08x13.19x1.24% 49.17B
Average -61.78x 9.17x 38.92x 2.22% 107.13B
Weighted average by Cap. -59.87x 9.29x 38.74x 2%

Y-o-Y evolution of P/E

Valuation ratios - P/E - DIAGNOS Inc.

Historical PBR trend

Valuation ratios - PBR - DIAGNOS Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - DIAGNOS Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - DIAGNOS Inc.

  1. Stock Market
  2. Stocks
  3. ADK Stock
  4. Valuation DIAGNOS Inc.